UBS Group Increases Allstate (NYSE:ALL) Price Target to $225.00

Allstate (NYSE:ALL) had its price target hoisted by UBS Group from $216.00 to $225.00 in a research report released on Monday,Benzinga reports. UBS Group currently has a buy rating on the insurance provider’s stock.

Several other brokerages have also commented on ALL. Morgan Stanley increased their price objective on shares of Allstate from $202.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Barclays lifted their target price on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. Piper Sandler lifted their target price on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a report on Friday, August 16th. Wells Fargo & Company dropped their price target on shares of Allstate from $177.00 to $175.00 and set an “equal weight” rating on the stock in a research note on Friday, August 16th. Finally, Raymond James lifted their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $210.31.

Allstate Trading Up 0.9 %

Shares of ALL opened at $190.55 on Monday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. Allstate has a fifty-two week low of $127.93 and a fifty-two week high of $198.79. The stock has a market capitalization of $50.46 billion, a PE ratio of 12.34, a P/E/G ratio of 1.71 and a beta of 0.48. The company’s fifty day moving average is $188.89 and its 200 day moving average is $175.59.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period in the previous year, the firm earned $0.81 earnings per share. The business’s revenue was up 14.7% on a year-over-year basis. Sell-side analysts expect that Allstate will post 15.23 earnings per share for the current fiscal year.

Insider Activity at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 in the last 90 days. 1.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Allstate

Large investors have recently modified their holdings of the stock. Northwest Investment Counselors LLC acquired a new stake in shares of Allstate in the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new stake in shares of Allstate in the third quarter valued at about $29,000. Versant Capital Management Inc increased its position in shares of Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. acquired a new stake in shares of Allstate in the second quarter valued at about $38,000. Finally, MCF Advisors LLC increased its position in Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after buying an additional 84 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.